We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DY icon
1601
Dycom Industries
DY
$11.8B
-5,748
Closed -$512K
DYN icon
1602
Dyne Therapeutics
DYN
$4.87B
-184,010
Closed -$1.65M
EBS icon
1603
Emergent Biosolutions
EBS
$260M
-10,946
Closed -$37K
ECL icon
1604
Ecolab
ECL
$78.9B
-14,886
Closed -$2.52M
ECPG icon
1605
Encore Capital Group
ECPG
$2.15B
-19,776
Closed -$945K
ED icon
1606
Consolidated Edison
ED
$39.3B
-49,286
Closed -$4.21M
EE icon
1607
Excelerate Energy
EE
$1.23B
-11,555
Closed -$197K
EEM icon
1608
CALL
iShares MSCI Emerging Markets ETF
EEM
$31.2B
-1,250,000
Closed -$47.4M
EFC
1609
Ellington Financial
EFC
$1.76B
-169,438
Closed -$2.11M
EG icon
1610
Everest Group
EG
$14.2B
-11,156
Closed -$4.15M
EGY icon
1611
Vaalco Energy
EGY
$625M
-39,653
Closed -$174K
EHC icon
1612
Encompass Health
EHC
$11.9B
-9,663
Closed -$649K
EIG icon
1613
Employers Holdings
EIG
$865M
-15,088
Closed -$603K
ELEV
1614
DELISTED
Elevation Oncology
ELEV
-999,546
Closed -$662K
ELS icon
1615
Equity Lifestyle Properties
ELS
$12.7B
-53,428
Closed -$3.4M
EMBC icon
1616
Embecta
EMBC
$296M
-39,252
Closed -$591K
EMR icon
1617
Emerson Electric
EMR
$87.7B
-634,504
Closed -$61.3M
ENB icon
1618
Enbridge
ENB
$110B
-14,368
Closed -$477K
ENOV icon
1619
Enovis
ENOV
$1.5B
-23,585
Closed -$1.24M
ENTA icon
1620
Enanta Pharmaceuticals
ENTA
$392M
-26,329
Closed -$294K
ENVA icon
1621
Enova International
ENVA
$6.05B
-14,753
Closed -$750K
EOG icon
1622
EOG Resources
EOG
$80.3B
-24,494
Closed -$3.1M
EPC icon
1623
Edgewell Personal Care
EPC
$1.32B
-20,851
Closed -$771K
EQH icon
1624
Equitable Holdings
EQH
$13.3B
-125,336
Closed -$3.56M
EQIX icon
1625
Equinix
EQIX
$105B
-50,084
Closed -$36.4M

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.